Inventor · disambiguated record
Michael David Shultz
Also filed as: SHULTZ MICHAEL · SHULTZ MICHAEL D · SHULTZ MICHAEL DAVID
21 granted patents·10 pending applications·61 citations·filing 2007–2023
93Inventor score
Files withNOVARTIS AG20CAFERRO THOMAS RAYMOND3CHEUNG ATWOOD KIM2MCQUIRE LESLIE WIGHTON2CHEN CHRISTINE HIU-TUNG1
Top patents by PatentIndex Score
31 records- 0191US9163003B24-piperidinyl compounds for use as tankyrase inhibitorsCHEN CHRISTINE HIU-TUNG·Filed 2012·Granted Oct 20, 2015·13 cites·20 claims
- 0290US11485742B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Nov 1, 2022·2 cites·22 claims
- 0389US11548865B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Jan 10, 2023·2 cites·29 claims
- 0486US10287266B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted May 14, 2019·8 cites·13 claims
- 0585US8957068B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2012·Granted Feb 17, 2015·13 cites·28 claims
- 0684US9434719B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2014·Granted Sep 6, 2016·7 cites·16 claims
- 0783US7943652B2Hydroxamate-based inhibitors of deacetylases BNOVARTIS AG·Filed 2009·Granted May 17, 2011·6 cites·42 claims
- 0881US10975080B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted Apr 13, 2021·2 cites·3 claims
- 0980US9688672B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2016·Granted Jun 27, 2017·2 cites·14 claims
- 1079US9181266B22-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitorsCHEUNG ATWOOD KIM·Filed 2012·Granted Nov 10, 2015·3 cites·13 claims
- 1177US2024140959A12-azaspiro[3.4]octane derivatives as m4 agonistsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1276US8362063B2Arylsulfonamide based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2012·Granted Jan 29, 2013·2 cites·6 claims
- 1374US11820778B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Nov 21, 2023·0 cites·30 claims
- 1470US12122761B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Oct 22, 2024·0 cites·25 claims
- 1566US9227982B24-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitorsCHEUNG ATWOOD KIM·Filed 2012·Granted Jan 5, 2016·1 cites·13 claims
- 1666US2021309663A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1765US2022089597A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1864US9822092B2ArylSulfonamide-based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2014·Granted Nov 21, 2017·0 cites·15 claims
- 1960US8975439B2Arylsulfonamide based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2012·Granted Mar 10, 2015·0 cites·7 claims
- 2060US8222424B2Arylsulfonamide-based matrix metalloprotease inhibitorsEHRHARDT CLAUS·Filed 2009·Granted Jul 17, 2012·0 cites·6 claims
- 2159US2014275083A13-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idhCAFERRO THOMAS RAYMOND·Filed 2014·Application pending·0 cites
- 2257US10112931B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2017·Granted Oct 30, 2018·0 cites·11 claims
- 2356USRE46942E4-piperidinyl compounds for use as tankyrase inhibitorsNOVARTIS AG·Filed 2012·Granted Jul 10, 2018·0 cites·36 claims
- 2453US2011112076A1Selective hydroxamic acid based mmp-12 and mmp-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2009·Application pending·0 cites
- 2547US2010008923A1Organic CompoundsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 2646US8349883B2Hydroxamate-based inhibitors of deacetylases BNOVARTIS AG·Filed 2011·Granted Jan 8, 2013·0 cites·34 claims
- 2745US8841291B2Selective hydroxamic acid based MMP-12 and MMP-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2013·Granted Sep 23, 2014·0 cites·2 claims
- 2843US2010022514A1Heterocycle Compounds and Methods of Use ThereofNORVARTIS AG·Filed 2007·Application pending·0 cites
- 2939US2016039802A13-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idhCHO YOUNG SHIN·Filed 2014·Application pending·0 cites
- 3036US2011053925A1Hydroxamate-Based Inhibitors of DeacetylasesNOVARTIS AG·Filed 2010·Application pending·0 cites
- 3135US2011060009A1Hydroxamate-Based Inhibitors of DeacetylasesNOVARTIS AG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael David Shultz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →